A study found in the National Library of Medicine (NLM) shows that the three most common side effects experienced by patients undergoing dulaglutide treatment are nausea, diarrhea, and vomiting
A cash-pay order gives you price visibility before checkout, but it should not be used as a reason to change the medication strength or treatment schedule on your own
The CMAJ guidance A guidance article published in the Canadian Medical Association Journal (CMAJ) on glucagon-like peptide-1 receptor agonists during pregnancy and lactation concluded that while the safety data is limited, the pharmacological properties of GLP-1 agonists (large molecular weight, poor oral bioavailability) suggest low theoretical risk during breastfeeding
Not the usual hype
Increased injection frequency risks Each subcutaneous injection carries a small risk of infection, bruising, and tissue damage
Official supply shortages persisted for most of 2024, as surging demand for AOMs continued to outstrip product supply, despite limited reimbursement, which presented an opportunity quickly seized upon by U.S